Yevgeny Brudno, Ph.D.

Yevgeny (Yev) Brudno received dual B.A. degrees in Chemistry and Biophysics from the University of Pennsylvania and his PhD in Organic Chemistry from Harvard University, working with David Liu to develop directed evolution technologies. From there, Yev worked as a postdoctoral fellow at the Wyss Institute at Harvard with Prof. David Mooney, developing controlled release drug delivery technologies for cancer and regenerative medicine. Yev’s research interests span organic synthetic chemistry, materials science, and cellular immunotherapy. Mostly recently, his lab develops materials to improve cell therapies, including CAR T cells. Our lab’s research is rooted in the belief that advances in chemistry and the basic molecular sciences can generate meaningful change in how therapies are designed, produced, and administered.